Fermentalg SA (EPA:ALGAE)
France · Delayed Price · Currency is EUR 0.5170
-0.0200 (-3.72%)
Apr 2, 2026, 5:35 PM CET
Fermentalg Revenue
In the year 2025, Fermentalg had annual revenue of 14.91M EUR with 29.69% growth. Fermentalg had revenue of 7.61M in the half year ending June 30, 2025, with 225.00% growth.
Revenue
14.91M
Revenue Growth
+29.69%
P/S Ratio
3.11
Revenue / Employee
236.68K
Employees
63
Market Cap
46.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.91M | 3.41M | 29.69% |
| Dec 31, 2024 | 11.50M | 7.44M | 183.39% |
| Dec 31, 2023 | 4.06M | -3.59M | -46.95% |
| Dec 31, 2022 | 7.65M | 2.00M | 35.43% |
| Dec 31, 2021 | 5.65M | 3.44M | 156.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 27.16M |
| Adocia | 12.88M |
| Innate Pharma | 9.01M |
| Advicenne | 5.90M |
| MaaT Pharma | 3.92M |
| Nicox | 3.32M |
| Aelis Farma | 2.33M |
| Valerio Therapeutics Société anonyme | 1.83M |